Related Experiment Videos

Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein

W Kraus1, E Haanes-Fritz, P P Cleary

  • 1Veterans Administration Medical Center, Memphis, TN 38104.

Insights

The N-terminal region of type 1 M protein contains key epitopes for protective immunity against streptococci. This finding supports the development of novel vaccines for group A streptococcal infections.

Area of Science:

  • Microbiology
  • Immunology
  • Protein Chemistry

Background:

  • Streptococcus pyogenes (group A Streptococcus) is a significant human pathogen.
  • M proteins are major virulence factors on the streptococcal surface, mediating resistance to phagocytosis.
  • Understanding M protein structure and function is crucial for vaccine development.

Purpose of the Study:

  • To determine the N-terminal sequence and structural characteristics of type 1 M protein.
  • To identify regions of type 1 M protein that elicit protective immune responses.
  • To assess the potential of type 1 M protein for vaccine development against group A Streptococcus.

Main Methods:

  • Automated Edman degradation of pepsin-digested M protein fragments.
  • Purification of polypeptide fragments using SDS-polyacrylamide gel electrophoresis and electroelution.
  • Comparison of determined sequences with predicted structures from gene sequences.
  • Synthesis of a 23-residue peptide for antibody induction studies.

Main Results:

  • Three M protein fragments (28-, 25-, and 23.5-kDa) were purified and sequenced.
  • The N-terminal region (residues 1-36) contains sequences critical for M protein structure and function.
  • A synthetic N-terminal peptide induced opsonic antibodies against type 1 Streptococcus.
  • The N-terminal region exhibits secondary structural periodicity similar to other M proteins, with limited repeats.

Conclusions:

  • The N-terminal region of type 1 M protein possesses structural features common to other M serotypes.
  • This region contains critical epitopes that induce protective, opsonic antibodies.
  • These findings have implications for designing safe and effective vaccines against group A streptococcal infections.

Related Concept Videos